Herbal medicines granted a traditional herbal registration (THR)

AI Summary

This summary focuses on the regulatory framework established by the UK Medicines and Healthcare products Regulatory Agency (MHRA) regarding the Traditional Herbal Registration (THR) scheme. This scheme allows herbal medicines intended for self-limiting conditions to be registered for use in the UK. Unlike standard pharmaceuticals, these products are evaluated based on a history of traditional use—specifically at least 30 years, including 15 years within the UK or EU—rather than modern clinical trials. Although the provided text does not specify a particular company or inspection dates, the regulation applies to all manufacturers seeking to market traditional herbal remedies. The main issues often encountered involve maintaining rigorous quality control and ensuring products are not adulterated. Required actions for compliance include the submission of a detailed technical dossier that demonstrates the product's safety profile and consistent manufacturing quality. This registration ensures that traditional products meet the same safety benchmarks as standard medicines. By adhering to these guidelines, companies provide consumers with reliable access to traditional treatments while remaining within the legal boundaries of the UK’s human medicines regulations.